DAY TWO - Thursday July 25, 2024
8:00 am Morning Coffee & Networking
9:15 am Chair’s Opening Remarks
Supercharging Non-Invasive Diagnostic tools to Spearhead Innovative Therapeutics for Endometriosis
9:30 am Panel Discussion: The Array of Perspectives on Endometriosis: From Biotech to Doctor to Patient
Synopsis
- Reaffirming the perspective of the patient to appreciate the current journey in alleviating symptoms experienced with endometriosis
- Hearing the current stance of clinicians and doctors in the diagnosis and treatment of endometriosis and the goals of healthcare services in the near future
- Elevating the variance in symptoms and symptom severity to create a more holistic profile for clinicians and biotechnology companies to consider in the development of next-generation therapies
10:15 am Revealing the Potential for Diagnostic Blood Sample Available to Identify Endometriosis
Synopsis
- Leveraging non-invasive biomarkers to create an accurate and accessible diagnostic tool for endometriosis
- Utilizing the menstrual blood samples to provide the necessary information to confidently diagnose endometriosis
- Sharing the histological data points which signify the degree of severity within a endometriotic blood sample
Revolutionizing the Next-Generation of Therapeutic Tools in the Treatment of Endometriosis
10:45 am Building Upon the Extensive Research into Menstrual Blood Samples to Create Non-Invasive Diagnostic Techniques
Synopsis
- Leveraging the ability of the uterus to act as a sentinel for female reproductive health and expanding to a molecular level
- Implementing in-depth data collection processes to help associate genomic information within samples to discrete health outcomes
- Translating the vast data points to precise mechanisms within the uterus to indicate the appropriate treatment method
11:15 am Morning Refreshments & Networking
11:45 am Discussing the Promising Potential of Cannabinoids for Treatment of Endometriosis
Synopsis
- Advancing understanding of the endocannabinoid system in relation to women’s health indications
- Enlightening the potential of cannabinoids in treating gynaecological conditions
- Defining the current state of evidence regarding cannabinoids therapeutics and endometriosis outcomes
12:15 pm Optimization of Non-Hormonal Kinase Inhibitors for Safe and Effective Treatment of Endometriosis
Synopsis
- Providing background to support kinase inhibitor target selection for treatment of endometriosis
- Sharing pre-clinical and clinical evidence to support efficacy of kinase inhibitor in treatment of women with endometriosis
- Outlining new discovery efforts coupled with parallel biomarker definition to optimize treatment outcomes in women with endometriosis
12:45 pm Modulating the Inflammatory Axis in the Development of a Robust Therapeutic Platform in the Treatment of Endometriosis
Synopsis
- Showcasing the efficacy of non-hormonal, anti-inflammatory drug therapeutics to alleviate symptoms of endometriosis
- Sharing pre-clinical to clinical progression in the development of endometriosis therapeutics and the requirements of IND submission
- Reviewing the process of data collection to ensure sufficient coverage of the female demographic is accounted for in trial analyses
1:15 pm Lunch & Networking
Brainstorming the Array of Technology Available Across Female Reproductive Systems, including the Advancing Research into the Menopause
2:15 pm Disrupting the IUD Market to Provide an Alternative Technology to Address an Array of Disease Indications
Synopsis
- Showcasing the new wave of IUD design since the T-Shape IUD has not changed in over 40 years
- Revealing a novel IUD system, addressing the triggers for pain and decreasing barriers for adoption
- Rationalizing an IUD drug delivery platform as the future for treatments better served inside the uterus
2:45 pm Focusing the Current Understanding of Ovarian Health Longevity to Combat Severe Symptoms of the Menopause
Synopsis
- Developing novel therapeutics capable of reducing age-related decline in ovarian function and extending female health span
- Addressing the fundamental causal factors of ovarian aging to preserve function of the reproductive system
- Monitoring ovarian reserve to track the depletion over time and implement therapeutics before significant reduction
3:15 pm Roundtable Discussion: Meeting Summary: The Action Points for Biotech and Pharma to Spearhead the Advancement of Women’s Health Therapeutics & Diagnostics
Synopsis
Your ultimate opportunity to collaborate as a community and define the clear next steps to drive innovation of women’s health products from bench side to bed side, continuing to raise the profile of women’s reproductive health as a priority across health care